To inform decision-making at the national and local levels, with regard to
healthcare, there is a recognized to understand the pharmaceutical sector and
health insurance system. This is because health insurance, reimbursement for
essential drugs, capability, capacity of pharmacy outlets, and inspection of maximum price control of essential drugs
needs to be monitored. The purpose of this study is to create and improve a
beginning understanding of the reimbursement of essential drugs from the supply
and demand sides.